Cargando…
Bitter orange (Citrus aurantium L.) extract subchronic 90-day safety study in rats
Bitter orange (Citrus aurantium L.) extracts are widely used in dietary supplements and bitter oranges are used in various juices and food products. p-Synephrine, the primary active constituent, comprises approximately 90% of total protoalkaloids. This study, performed per OECD 408 guidance, examine...
Autores principales: | Deshmukh, N.S., Stohs, S.J., Magar, C.C., Kale, A., Sowmya, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686423/ https://www.ncbi.nlm.nih.gov/pubmed/29214145 http://dx.doi.org/10.1016/j.toxrep.2017.11.002 |
Ejemplares similares
-
Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p‐Synephrine
por: Stohs, Sidney J.
Publicado: (2017) -
A Review of the Human Clinical Studies Involving Citrus aurantium (Bitter Orange) Extract and its Primary Protoalkaloid p-Synephrine
por: Stohs, Sidney J., et al.
Publicado: (2012) -
Effects of Citrus Aurantium (Bitter Orange) on the Severity of First-Stage Labor Pain
por: Namazi, Masoumeh, et al.
Publicado: (2014) -
The Safety and Efficacy of Citrus aurantium (Bitter Orange) Extracts and p-Synephrine: A Systematic Review and Meta-Analysis
por: Koncz, Dorottya, et al.
Publicado: (2022) -
Effects of Citrus aurantium (Bitter Orange) Fruit Extracts and p-Synephrine on Metabolic Fluxes in the Rat Liver
por: Peixoto, Jéssica Sereno, et al.
Publicado: (2012)